These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20464672)

  • 1. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty.
    Salapura V; Blinc A; Kozak M; Jezovnik MK; Pohar Perme M; Berden P; Kuhelj D; Kljucevsek T; Popovic P; Stankovic M; Vrtovec M; Surlan M
    Vasa; 2010 May; 39(2):159-68. PubMed ID: 20464672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revascularization by angioplasty of type D femoropopliteal and long infrapopliteal lesion in diabetic patients with critical limb ischemia: are TASC II recommendations suitable? A population-based cohort study.
    Faglia E; Clerici G; Airoldi F; Tavano D; Caminiti M; Curci V; Mantero M; Morabito A; Edmonds M
    Int J Low Extrem Wounds; 2012 Dec; 11(4):277-85. PubMed ID: 23089965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
    Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
    J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosis.
    Werner M; Scheinert D; Henn M; Scheinert S; Bräunlich S; Bausback Y; Friedenberger J; Schuster J; Hertting K; Piorkowski M; Rosner C; Schmidt A; Ulrich M; Gutberlet M
    J Endovasc Ther; 2012 Aug; 19(4):467-75. PubMed ID: 22891824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
    Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females?
    Maca T; Ahmadi R; Derfler K; Hörl WH; Koppensteiner R; Minar E; Schneider B; Stümpflen A; Ehringer H
    Atherosclerosis; 1996 Nov; 127(1):27-34. PubMed ID: 9006801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 11. Endovascular interventions for TASC II D femoropopliteal lesions.
    Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
    J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.
    Schillinger M; Haumer M; Schlerka G; Mlekusch W; Exner M; Ahmadi R; Minar E
    J Endovasc Ther; 2001 Oct; 8(5):477-83. PubMed ID: 11718406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous transluminal angioplasty and enclosed thrombolysis versus percutaneous transluminal angioplasty in the treatment of femoropopliteal occlusions: results of a prospective randomized trial.
    Nicholson T
    Cardiovasc Intervent Radiol; 1998; 21(6):470-4. PubMed ID: 9853164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R
    Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease.
    Schmidt A; Ulrich M; Winkler B; Klaeffling C; Bausback Y; Bräunlich S; Botsios S; Kruse HJ; Varcoe RL; Kum S; Scheinert D
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1047-54. PubMed ID: 20518006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
    Radak Dj; Laps KH; Jeger KA; Ilijevski N; Vojić M
    Srp Arh Celok Lek; 1998; 126(3-4):83-91. PubMed ID: 9863361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outback catheter for femoropopliteal occlusions: immediate and long-term results.
    Bausback Y; Botsios S; Flux J; Werner M; Schuster J; Aithal J; Varcoe R; Bräunlich S; Ulrich M; Scheinert D; Schmidt A
    J Endovasc Ther; 2011 Feb; 18(1):13-21. PubMed ID: 21314343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.